P Berto

Summary

Affiliation: pbe consulting

Publications

  1. ncbi request reprint [Cost analysis in Italy of various strategies for the treatment of Parkinson disease in the advanced phase]
    Anna D'Ausilio
    Chiesi Farmaceutici, Parma
    Recenti Prog Med 94:484-93. 2003
  2. ncbi request reprint Major complications have an impact on total annual medical cost of diabetes: results of a database analysis
    Andrea Morsanutto
    Centro di Farmacoeconomia, Universita degli Studi di Milano, Milano, Italy
    J Diabetes Complications 20:163-9. 2006
  3. ncbi request reprint [Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study]
    Chiara Schivazappa
    pbe consulting, Verona
    Recenti Prog Med 98:12-5. 2007
  4. pmc Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study
    Paolo A Cortesi
    CHARTA Foundation, Milan, Italy
    BMC Psychiatry 13:98. 2013
  5. doi request reprint Cost of laparoscopy and laparotomy in the surgical treatment of colorectal cancer
    Patrizia Berto
    PBE Consulting srl, Vicolo Agnello 6, 37121, Verona, Italy
    Surg Endosc 26:1444-53. 2012
  6. pmc Specific immunotherapy by the sublingual route for respiratory allergy
    Cristoforo Incorvaia
    Allergy Pulmonary rehabilitation, Istituti Clinici di Perfezionamento, Milan, Italy
    Allergy Asthma Clin Immunol 6:29. 2010
  7. ncbi request reprint Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma
    P Berto
    pbe consulting, Verona, Italy
    Eur Ann Allergy Clin Immunol 37:303-8. 2005
  8. ncbi request reprint Economic studies of immunotherapy: a review
    Patrizia Berto
    University of Padova, Padova, Italy
    Curr Opin Allergy Clin Immunol 8:585-9. 2008
  9. doi request reprint Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis
    Patrizia Berto
    pbe consulting, Vicolo Stella 6, Verona, Italy
    Aging Clin Exp Res 22:179-88. 2010
  10. doi request reprint The direct cost of patients with multiple sclerosis: a survey from Italian MS centres
    Berto P
    PBE Consulting srl, Vicolo Stella 6, 37121 Verona, Italy
    Neurol Sci 32:1035-41. 2011

Collaborators

Detail Information

Publications23

  1. ncbi request reprint [Cost analysis in Italy of various strategies for the treatment of Parkinson disease in the advanced phase]
    Anna D'Ausilio
    Chiesi Farmaceutici, Parma
    Recenti Prog Med 94:484-93. 2003
    ....
  2. ncbi request reprint Major complications have an impact on total annual medical cost of diabetes: results of a database analysis
    Andrea Morsanutto
    Centro di Farmacoeconomia, Universita degli Studi di Milano, Milano, Italy
    J Diabetes Complications 20:163-9. 2006
    ..Type 2 diabetes mellitus is a common, chronic, and costly disease, and its prevalence is increasing in major industrialized countries. Diabetes has indeed a high social impact mainly because of its chronic complications...
  3. ncbi request reprint [Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study]
    Chiara Schivazappa
    pbe consulting, Verona
    Recenti Prog Med 98:12-5. 2007
    ..With the exclusion of the pharmacological therapy, most of the difference in costs derives from nurses' labor costs, which is related to the longer infusion time for pamidronate (1 h, 47 min versus 28 min for zoledronic acid)...
  4. pmc Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study
    Paolo A Cortesi
    CHARTA Foundation, Milan, Italy
    BMC Psychiatry 13:98. 2013
    ..This study aimed to assess persistence, compliance, costs and Health-Related Quality-of-Life (HRQoL) in young patients undergoing antipsychotic treatment according to clinical practice...
  5. doi request reprint Cost of laparoscopy and laparotomy in the surgical treatment of colorectal cancer
    Patrizia Berto
    PBE Consulting srl, Vicolo Agnello 6, 37121, Verona, Italy
    Surg Endosc 26:1444-53. 2012
    ..This paper aims to fill this gap by providing economic information on this research topic of growing relevance at a time of reduced healthcare budgets...
  6. pmc Specific immunotherapy by the sublingual route for respiratory allergy
    Cristoforo Incorvaia
    Allergy Pulmonary rehabilitation, Istituti Clinici di Perfezionamento, Milan, Italy
    Allergy Asthma Clin Immunol 6:29. 2010
    ..In fact, a number of studies showed that SLIT may be very beneficial to the healthcare system, especially when its effectiveness persists after treatment withdrawal because of the induced immunologic changes...
  7. ncbi request reprint Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma
    P Berto
    pbe consulting, Verona, Italy
    Eur Ann Allergy Clin Immunol 37:303-8. 2005
    ..Aim of this study was to evaluate the economic effect of treatment with high dose sublingual immunotherapy (SLIT) in children...
  8. ncbi request reprint Economic studies of immunotherapy: a review
    Patrizia Berto
    University of Padova, Padova, Italy
    Curr Opin Allergy Clin Immunol 8:585-9. 2008
    ....
  9. doi request reprint Risedronate versus alendronate in older patients with osteoporosis at high risk of fracture: an Italian cost-effectiveness analysis
    Patrizia Berto
    pbe consulting, Vicolo Stella 6, Verona, Italy
    Aging Clin Exp Res 22:179-88. 2010
    ..The aim of this work was to assess the cost-effectiveness and health utility of risedronate vs generic alendronate in clinical practice in Italy, using effectiveness data from the REAL study...
  10. doi request reprint The direct cost of patients with multiple sclerosis: a survey from Italian MS centres
    Berto P
    PBE Consulting srl, Vicolo Stella 6, 37121 Verona, Italy
    Neurol Sci 32:1035-41. 2011
    ..The annual medical cost/patient is largely driven by the cost of drugs (89.2% of total); GA represents the least expensive bio-DMD in the Italian health-care setting...
  11. ncbi request reprint Quality of life in patients with epilepsy and impact of treatments
    Patrizia Berto
    pbe consulting, Verona, Italy
    Pharmacoeconomics 20:1039-59. 2002
    ..In the pursuit of developing valid, reliable and sensitive measures of quality of life, it seems no longer appropriate to consider seizure frequency alone...
  12. ncbi request reprint The pandora project: cost of hypertension from a general practitioner database
    Patrizia Berto
    pbe consulting, Verona, Italy
    Blood Press 11:151-6. 2002
    ..Data from 1,651 patients were followed up for I year in order to investigate the cost of hypertension. Only direct medical costs were considered in the perspective of the National Healthcare System...
  13. ncbi request reprint [Budgetary impact of pneumococcal conjugate vaccination of newborns]
    P Berto
    Facolta di Farmacia, Università degli Studi di Padova e pbe consulting, Verona
    Ann Ig 19:281-91. 2007
    ..Our analysis suggests that the use of PCV in infants is likely to be economically justified due to savings from pneumonia and AOM cases averted, in the population of newborns of Lombardy...
  14. ncbi request reprint Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study
    Patrizia Berto
    School of Pharmacy, University of Padova, and PBE Consulting, Verona, Italy
    Ann Allergy Asthma Immunol 97:615-21. 2006
    ..Few data are available on the pharmacoeconomic aspects of immunotherapy...
  15. ncbi request reprint [Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies]
    Chiara Schivazappa
    pbe consulting, Verona
    Recenti Prog Med 99:27-31. 2008
    ..zoledronic acid and pamidronate in chemotherapy-treated patients, and Euro 337 and Euro 419 lower in patients undergoing hormonal therapy; also, with a small increment in QALYs, ibandronate resulted as the dominant therapeutic option...
  16. ncbi request reprint Pharmacoeconomics and immunotherapy
    P Berto
    pbe consulting, Verona, Italy
    Eur Ann Allergy Clin Immunol 39:12-6. 2007
    ....
  17. ncbi request reprint Cost-of-illness of lung disease in the TriVeneto Region, Italy: the GOLD Study
    R Dal Negro
    Divisione di Pneumologia, Ospedale Orlandi, Bussolengo, Verona, Italy
    Monaldi Arch Chest Dis 57:3-9. 2002
    ..The use of preventive, specialised care could help in achieving early diagnosis and treatment of these patients...
  18. ncbi request reprint Health technology assessment (HTA): definition, role and use in the changing healthcare environment
    D Gallio
    pbe consulting, Verona, Italy
    Eur Ann Allergy Clin Immunol 39:7-11. 2007
    ....
  19. ncbi request reprint Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study
    Patrizia Berto
    School of Pharmacy, University of Padova, Italy PBE Consulting, Verona, Italy
    Curr Med Res Opin 24:261-6. 2008
    ....
  20. ncbi request reprint Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma
    Renato Ariano
    Allergy and Clinical Immunology Unit, General Hospital, Bordighera, Italy
    Allergy Asthma Proc 27:159-63. 2006
    ..These findings confirm some previous observations in studies from Germany and the United States that subcutaneous immunotherapy has significant economic advantages over antiallergic drug treatment in the long term...
  21. ncbi request reprint Cost-effectiveness analysis of PMMA, silicone, or acrylic intra-ocular lenses in cataract surgery in four European countries
    Andrew F Smith
    Health Economics Unit, Alcon Laboratories Ltd, Hemel Hempstead, England, UK
    Ophthalmic Epidemiol 12:343-51. 2005
    ....
  22. ncbi request reprint Major diabetes complications have an impact on total annual medical cost of type 2 diabetes
    Andrea Morsanutto
    Diabetes Care 27:1841-2. 2004
  23. ncbi request reprint Cost-effectiveness of enoxaparin as thromboprophylaxis in acutelly ill medical patients from the Italian NHS perspective
    Mark J C Nuijten
    MEDTAP International, Amsterdam
    Recenti Prog Med 93:80-91. 2002
    ..To determine the cost-effectiveness of thromboprophylaxis with enoxaparin versus no thromboprophlaxis in patients with acute medical illness in Italy from the NHS perspective...